Swiss Stocks End Week in Green; DocMorris Shares Jump

11:48 AM EDT, 10/16/2026 (MT Newswires) -- The blue-chip Swiss Market Index wrapped up the trading week in positive territory, closing Friday's session 0.29% higher, as markets mulled over a fresh batch of company and economy-related data releases. Roche (RO.SW) secured approval from the US Food and Drug Administration for Enspryng, or satralizumab, as an at-home subcutaneous treatment option for thyroid eye disease in adult patients, marking the second indication for the monoclonal antibody. The Swiss pharmaceutical major is also evaluating the drug for potential use in additional neurological autoimmune and inflammatory diseases. At the end of the trading day, the stock was down 0.41%. Deutsche Bank Research lifted its price target for DocMorris (DOCM.SW) to 17.50 francs from 12.50 francs and reiterated its buy rating on the stock, following the Switzerland-based online pharmacy's latest 2026 guidance upgrade. The company's shares gained 6.86% at closing. "The string of positive surprises at DocMorris continues, with the company now having raised its 2026 guidance twice. Management also appears to be sticking to its more conservative guidance philosophy, with even the upper end of the new 2026 sales target range not looking overly ambitious to us," the research firm said. "Hence, we see further scope for consensus upgrades, which should continue to support the shares despite their strong +140% YTD performance." Meanwhile, UBS Group (UBSG.SW) discussed the possibility of moving its listing and legal headquarters to the UK with former Chancellor Rachel Reeves during her tenure, the Financial Times reported, citing people briefed on the talks. Reeves reportedly pitched London as a possible new headquarters in case the Swiss bank decides to redomicile due to Switzerland's stricter capital rules. UBS, which rose 0.53%, declined to comment. On the economic front, the European Union's exports to Switzerland grew 11.8% year over year in August, while imports climbed 15.1%, resulting in the trade surplus rising to 5.3 billion euros from 5.1 billion euros. Meanwhile, the euro area's annual inflation rate increased to 3.8% in September from 3.2% in August, while the annual core inflation rate ticked up to 2.5% from 2.4%, Eurostat's final data showed.